🔎 Trials Near Me

Acasă › Leucemie acută bifinotipică › California

Studii clinice pentru Leucemie acută bifinotipică în California

15 studii pentru Leucemie acută bifinotipică caută participanți în California.

Orașe în California

Text oficial al studiului (în engleză)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • City of Hope, Duarte
  • UC Davis, Sacramento
  • Stanford Health Care, Stanford
În curs de recrutareFaza 1
Vârste de la 12 la 78 · Toate sexele · Actualizat 29 sept. 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • și încă 4
În curs de recrutareFaza 2
365 Days · Toate sexele · Actualizat 25 sept. 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • și încă 14
În curs de recrutareFaza 3
365 Days – 25 Years · Toate sexele · Actualizat 25 aug. 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Kaiser Permanente Downey Medical Center, Downey
  • Loma Linda University Medical Center, Loma Linda
  • Miller Children's and Women's Hospital Long Beach, Long Beach
  • și încă 8
În curs de recrutareFaza 1/2
Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

  • Rady Children's Hospital, San Diego
În curs de recrutareFaza 2
Vârste de la 1 la 18 · Toate sexele · Actualizat 10 aug. 2026 · NCT06390319

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • City of Hope, Duarte
  • Valkyrie Clinical Trials, Los Angeles
În curs de recrutareFaza 1/2
Vârste de la 13 la 90 · Toate sexele · Actualizat 6 aug. 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Rady Children's Hospital, San Diego
În curs de recrutareFaza 1
Vârste de la 1 la 30 · Toate sexele · Actualizat 3 aug. 2026 · NCT06177067

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

  • Rady Children's Hospital, San Diego
În curs de recrutareFaza 4
Vârste de la 1 la 18 · Toate sexele · Actualizat 14 iul. 2026 · NCT06289673

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • UCLA Department of Medicine, Los Angeles
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 7 iul. 2026 · NCT07216443

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

  • Stanford University, Palo Alto
În curs de recrutareFaza 1
Vârste de la 18 la 70 · Toate sexele · Actualizat 23 iun. 2026 · NCT06551584

A Study of Revumenib and Mezigdomide in People With Leukemia

  • City of Hope Cancer Center (Data collection only), Duarte
În curs de recrutareFaza 1/2
Vârste de 12 ani și peste · Toate sexele · Actualizat 22 iun. 2026 · NCT07356154

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • City of Hope, Duarte
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
  • și încă 1
În curs de recrutareFaza 1/2
Vârste de la 12 la 95 · Toate sexele · Actualizat 15 apr. 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • University of California San Francisco-Benioff Children's Hospital, San Francisco
În curs de recrutareFaza 1
Vârste de la 1 la 40 · Toate sexele · Actualizat 12 mar. 2026 · NCT05292664

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
În curs de recrutareFaza 1
Vârste de 2 ani și peste · Toate sexele · Actualizat 5 mar. 2026 · NCT06575296

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Children's Hospital Los Angeles, Los Angeles
  • Children's Hospital Orange County, Orange
  • UCSF School of Medicine, San Francisco
În curs de recrutareFaza 1
Vârste de la 1 la 21 · Toate sexele · Actualizat 6 dec. 2024 · NCT05476770

Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.